实用肝脏病杂志 ›› 2022, Vol. 25 ›› Issue (4): 595-598.doi: 10.3969/j.issn.1672-5069.2022.04.035

• 胆石症 • 上一篇    下一篇

3D模型指导下PTCSL微创治疗复杂性肝胆管结石患者效果研究*

黄鹏, 孟凡斌, 张晓农, 于延铭   

  1. 124000 辽宁省 盘锦市中心医院普外二科(黄鹏,张晓农,于延铭);中国医科大学附属第一医院胰胆外科(孟凡斌)
  • 收稿日期:2021-11-30 出版日期:2022-07-10 发布日期:2022-07-14
  • 通讯作者: 张晓农,E-mail:4100016919@qq.com
  • 作者简介:黄鹏,男,33岁,硕士研究生,主治医师。E-mail:pjhuangpeng@163.com
  • 基金资助:
    *辽宁省科学技术研究计划项目(编号:2017225139)

Efficacy of percutaneous transhepatic puncture choledochoscopic lithotomy under CT 3D guidance in the treatment of patients with complex hepatolithiasis

Huang Peng, Meng Fanbin, Zhang Xiao, et al   

  1. Second Division, Department of General Surgery, Central People’s Hospital,Panjin 124000,Liaoning Province, China
  • Received:2021-11-30 Online:2022-07-10 Published:2022-07-14

摘要: 目的 探讨CT三维重建(3D)技术模型指导经皮经肝穿刺胆道镜取石术(PTCSL)治疗复杂性肝胆管结石患者的效果。方法 2018年6月~2020年6月我院收治的复杂性肝胆管结石患者136例,其中74例(观察组)接受3D模型指导下PTCSL手术取石,另62例(对照组)常规行PTCSL治疗。术后,随访12个月。结果 观察组手术时间、术中出血量和住院日分别为(98.1±30.2)min、(32.5±10.5)mL和(8.9±1.6)d,显著短于或少于对照组[分别为(129.7±36.7)min、(36.9±14.3)mL和(10.8±2.8)d,P<0.05];两组手术前后血生化指标比较,无显著性差异(P>0.05);术后,观察组并发症发生率为4.1%,显著低于对照组的14.5%(P<0.05);在术后1个月复查CT,观察组结石清除率为97.3%,显著高于对照组的85.5%(P<0.05),出院后随访12个月,观察组失访5例,对照组失访2例。经CT检查,观察组结石复发率为2.9%(2/69),对照组为15.0%(9/60,x2=6.026,P=0.014)。结论 在3D模型引导下行PTCSL治疗复杂性肝胆管结石患者可提高结石清除率,减少手术时间和术中出血量,降低术后并发症发生率和住院日,远期疗效也较好。

关键词: 肝胆管结石, CT三维重建, 经皮经肝穿刺胆道镜取石术, 治疗

Abstract: Objective The aim of this study was to investigate the efficacy of percutaneous transhepatic puncture choledochoscopic lithotomy (PTCSL) under CT three-dimensional reconstruction (3D) guidance in the treatment of patients with complex hepatolithiasis. Methods A total of 136 patients with complicated hepatobiliary stones were admitted to our hospital between June 2018 and June 2020, and 74 patients in observation group were treated by PTCSL under 3D guidance and 62 patients received PTCSL routinely. All patients were followed-up for 12 months. Results The operative time, intraoperative blood loss and hospital stay in the observation group were (98.1±30.2) min, (32.5±10.5) mL and (8.9±1.6) d, significantly shorter or less than [(129.7±36.7) min, (36.9±14.3) mL and (10.8±2.8) d, P< 0.05] in the control group; there were no significant differences as respect to blood biochemical parameters between the two groups (P>0.05); after operation, the incidence of complications in the observation was 4.1%, significantly lower than 14.5%(P<0.05) in the control; one month after operation, the CT scan showed that the clearance of stone in the observation was 97.3%, significantly higher than 85.5%(P<0.05) in the control; at the end of 12 month followed-up, 5 patients in the observation and 2 patients in the control lost, with the relapse of hepatobiliary stone as demonstrated by CT scan of 2.9%(2/69) and 15.0%(9/60, x2=6.026, P=0.014) in the two groups. Conclusion The PTCSL operation as guided under 3D technology in the treatment of patients with complex hepatolithiasis could improve the stone clearance rate, with reduction of operation time, intraoperative blood loss and hospital stay, which might have a promising efficacy with less residual of stone.

Key words: Hepatolithiasis, CT three-dimensional reconstruction, Percutaneous transhepatic puncture choledochoscopic lithotomy, Therapy